Management of Graft-Versus-Host Disease in Paediatric Bone Marrow Transplant Recipients
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Pediatric Drugs
- Vol. 2 (1) , 29-55
- https://doi.org/10.2165/00148581-200002010-00004
Abstract
We discuss clinical strategies for the prophylaxis and treatment of both acute and chronic graft-versus-host disease (GVHD) with particular attention to children.Grades II to IV acute GVHD occur in 10 to 50% of patients given an allogeneic transplantation of haemopoietic stem cells (HSCT) frKeywords
This publication has 194 references indexed in Scilit:
- Thalidomide and the immune system 3. simultaneous up- and down-regulation of different integrin receptors on human white blood cellsLife Sciences, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Thalidomide and the immune system 2. Changes in receptors on blood cells of a healthy volunteerLife Sciences, 1992
- Chronic Graft–Vs.–Host Disease of the Liver: Another Indication of Ursodeoxycholic Acid?Hepatology, 1992
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reactionJournal of the American Academy of Dermatology, 1985
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979